Dtsch Arztebl Int 2021 Feb;118(7):101-108
Bavarian State Office for Health and Food Safety: Health Reporting, Epidemiology, Social Medicine, Child Health, Screening Center, Oberschleißheim; Institute for Experimental Pediatric Endocrinology, Charité-University Medical Center Berlin; Department of Child Nutrition, Federal Research Institute of Nutrition and Food, Max Rubner Institute, Karlsruhe; Department of General Pediatrics, Neonatology, and Pediatric Cardiology, University Children's Hospital, Heinrich Heine University Düsseldorf; The Hospital for Sick Children and University of Toronto, Canada; Neonatal Metabolic Screening, Hessian Center for Preventive Care in Children, Screening Center; Hesse, University Hospital Frankfurt/Main.
Background: The purpose of neonatal screening is the early detection of congenital metabolic and endocrine disorders that, if untreated, could lead to fatal crises or other long-term adverse sequelae. In Germany, neonatal screening is legally regulated. Quality-assurance reports ("DGNS reports") are created and published annually by the German Society for Neonatal Screening (Deutsche Gesellschaft für Neugeborenen-Screening). Read More